Cite
HARVARD Citation
Joustra, V. et al. (n.d.). OP29 Peripheral blood DNA methylation biomarkers accurately predict clinical- and endoscopic response to vedolizumab in a real-life cohort of Crohn's Disease patients. Journal of Crohn's and colitis. pp. i032-i033. [Online].